Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 538 participants.
Also called NCT07476859
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 538 participants
- Registry
-
NCT07476859
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07476859. Randomized; no masking; primary purpose treatment. Start 2026-03-05 (actual); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
- Acronym
- HI-COR-65
- Condition
- Acute Coronary Syndromes (ACS)
- Condition
- Iron Deficiencies
- Condition
- Elderly (People Aged 65 or More)
- Intervention (Drug)
- Ferric Carboxymaltose Injection [Ferinject]
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct07476859- Content hash
fe829d6dd7209b2acc7a89d264f3f65122905b222fb2f5ee8b9f1185ebe65374